Stock ENOV ENOVIS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Enovis Corporation

Equities

ENOV

US1940145022

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-10 pm EDT 		5-day change 1st Jan Change
51.07 USD +0.04% Intraday chart for Enovis Corporation -0.39% -8.84%
May. 02 Enovis Q1 Shares Fall Following Q1 Results MT
May. 02 Transcript : Enovis Corporation, Q1 2024 Earnings Call, May 02, 2024

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 4,284 4,530 7,115 2,898 3,058 2,801 - -
Enterprise Value (EV) 1 6,486 6,664 8,483 2,898 3,293 4,035 4,013 3,966
P/E ratio -9.35 x 123 x 99.9 x -214 x -91.8 x -111 x 49.1 x 35.8 x
Yield - - - - - - - -
Capitalization / Revenue 1.29 x 1.48 x 1.85 x 1.85 x 1.79 x 1.32 x 1.23 x 1.13 x
EV / Revenue 1.95 x 2.17 x 2.2 x 1.85 x 1.93 x 1.9 x 1.76 x 1.61 x
EV / EBITDA 12.8 x 14.4 x 13.6 x 12.3 x 12.2 x 10.8 x 9.61 x 8.69 x
EV / FCF 1,170 x 35.6 x 33.7 x -18 x 258 x 90.5 x 27.5 x 10 x
FCF Yield 0.09% 2.81% 2.97% -5.57% 0.39% 1.1% 3.63% 9.97%
Price to Book 1.25 x 1.28 x 1.56 x - 0.89 x 0.86 x 0.88 x 0.9 x
Nbr of stocks (in thousands) 39,252 39,486 51,594 54,150 54,594 54,851 - -
Reference price 2 109.1 114.7 137.9 53.52 56.02 51.07 51.07 51.07
Announcement Date 2/21/20 2/18/21 2/22/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,327 3,071 3,854 1,563 1,707 2,126 2,282 2,471
EBITDA 1 504.9 463.2 623.1 236.1 269.2 374.8 417.5 456.3
EBIT 1 268.9 217 360.1 159.4 185.6 259.7 291.2 325.2
Operating Margin 8.08% 7.07% 9.34% 10.2% 10.87% 12.22% 12.76% 13.16%
Earnings before Tax (EBT) 1 50.49 58.03 165.4 -2.069 -67.13 -117.6 31.02 -29.9
Net income 1 -527.6 42.62 71.66 -13.29 -33.26 -29.52 46.77 39.6
Net margin -15.86% 1.39% 1.86% -0.85% -1.95% -1.39% 2.05% 1.6%
EPS 2 -11.67 0.9300 1.380 -0.2500 -0.6100 -0.4617 1.040 1.428
Free Cash Flow 1 5.546 187.2 251.9 -161.3 12.76 44.58 145.8 395.3
FCF margin 0.17% 6.09% 6.53% -10.32% 0.75% 2.1% 6.39% 16%
FCF Conversion (EBITDA) 1.1% 40.4% 40.42% - 4.74% 11.89% 34.92% 86.64%
FCF Conversion (Net income) - 439.06% 351.48% - - - 311.75% 998.23%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/21/20 2/18/21 2/22/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,023 375.5 395.1 383.8 408.7 406.2 428.5 417.5 455 516.3 529.6 515 565.7 553.6 573.8
EBITDA 1 156.7 47.7 56.2 57.21 74.9 56.4 65.7 65.4 81.7 83.2 90.15 91.65 110.2 88.72 101
EBIT 1 91.4 29.1 36.7 39.05 54.3 36.4 44.9 43.9 60.3 56 61.82 61.22 80.71 59.53 70.46
Operating Margin 8.93% 7.75% 9.29% 10.17% 13.29% 8.96% 10.48% 10.51% 13.25% 10.85% 11.67% 11.89% 14.27% 10.75% 12.28%
Earnings before Tax (EBT) 1 39.82 -46.2 116.4 -78.28 -2.54 -29.96 -19.32 -25.5 7.657 -79.24 -21.53 -17.77 0.9333 -23.2 -10.2
Net income 1 -1.907 -39.4 76.86 -66.61 -38.6 -23.35 -9.995 -2.88 2.964 -72 1.663 3.136 17.68 -18.6 -8.3
Net margin -0.19% -10.49% 19.45% -17.36% -9.45% -5.75% -2.33% -0.69% 0.65% -13.95% 0.31% 0.61% 3.13% -3.36% -1.45%
EPS 2 -0.0300 -0.7243 1.410 -1.230 -0.7100 -0.4300 -0.1800 -0.0500 0.0500 -1.320 0.0817 0.1017 0.3667 0.0350 0.2250
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 2/22/22 5/10/22 8/4/22 11/2/22 2/23/23 5/4/23 8/3/23 11/7/23 2/22/24 5/2/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,202 2,134 1,368 - 235 1,234 1,212 1,165
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 4.361 x 4.607 x 2.195 x - 0.8729 x 3.291 x 2.903 x 2.553 x
Free Cash Flow 1 5.55 187 252 -161 12.8 44.6 146 395
ROE (net income / shareholders' equity) 8.12% 5.55% 8.14% 3.07% 3.85% 4.41% 5.5% 6.66%
ROA (Net income/ Total Assets) -7.54% 0.58% 4.19% 1.93% - - - -
Assets 1 7,001 7,369 1,711 -687.1 - - - -
Book Value Per Share 2 87.50 89.70 88.70 - 62.60 59.20 58.00 57.00
Cash Flow per Share 2.870 6.520 6.870 - - - - -
Capex 1 125 115 104 105 122 135 142 148
Capex / Sales 3.77% 3.74% 2.7% 6.75% 7.16% 6.37% 6.23% 5.99%
Announcement Date 2/21/20 2/18/21 2/22/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Enovis Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
51.07 USD
Average target price
74.1 USD
Spread / Average Target
+45.09%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
ENOVIS CORPORATION Stock Enovis Corporation
-8.84% 2.8B
STRYKER CORPORATION Stock Stryker Corporation
+10.39% 126B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-6.86% 10.96B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+2.52% 8.97B
GLAUKOS CORPORATION Stock Glaukos Corporation
+38.96% 5.56B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-17.50% 4.99B
AXONICS, INC. Stock Axonics, Inc.
+8.36% 3.44B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-7.52% 2.18B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-3.00% 2.16B
DOUBLE MEDICAL TECHNOLOGY INC. Stock Double Medical Technology Inc.
-21.88% 1.82B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. ENOV Stock
  4. Financials Enovis Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW